Opioid Consumption in Cystectomy Patients

NCT03032822 | Terminated

• 1 other identifier: 2017H0430
• Study Type: observational
• Target: 47
• Locations: 1 country
• Sites: 1

Brief Summary

At the Ohio State University, and across the country, surgical patients admitted to the hospital are over-prescribed a significant amount of opioid medications upon discharge to home. Recent studies reveal that a large percentage of patients prescribed opioid medications after surgery have approximately half of the prescribed medication left over. This study aims to evaluate reported opioid use after surgery in patients undergoing cystectomy in order to better approach the issue with current opioid use and abuse trends while still providing adequate medical care and pain management to patients.

Conditions

Cystostomy; Complications; Opioid Use

Keywords

Opioid consumption; postdischarge; cystectomy

Outcome Measures

Primary Outcomes (1)

• opioid consumption over time

  The opioid medication (oral morphine equivalent) taken by the patients will be assessed every week until the sixth postoperative week, to compare it with the amount prescribed by the physicians

  once per week, up to six weeks after surgery

Study Arms (1)

All Patients

All cystectomy patients who consent for the study

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adult patients at the OSUMC, 18 years of age and older scheduled to undergo a cystecotomy, who give written informed consent to participate in the study and who meet all inclusion and no exclusion criteria

You may qualify if:

• patients undergoing cystectomy
• Capable and willing to consent
• Participants literate in English language

You may not qualify if:

• History of drug and/or alcohol abuse/dependency
• Ketamine use during hospitalization
• Illiteracy
• Presence of a clinically diagnosed major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia
• Any condition that the principle investigator may disqualify the patient

Sponsors & Collaborators

• Ohio State University: lead

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

Study Officials

• Tristan E Weaver, MD

  Ohio State University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor - Clinical

Study Record Dates

• First Submitted: January 24, 2017
• First Posted: January 26, 2017
• Study Start: January 17, 2018
• Primary Completion: September 30, 2021
• Study Completion: September 30, 2021
• Last Updated: March 27, 2025

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)